Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/05/1991 | CA1280975C Method and compositions for making liposomes |
03/05/1991 | CA1280974C Transdermal delivery system |
03/05/1991 | CA1280973C Analgesic stick compositions |
03/02/1991 | CA2023995A1 Stable solutions of mitomycin c |
03/02/1991 | CA2021548A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
03/01/1991 | WO1991003227A1 Topical antiinflammatory compositions with minimal systemic absorption |
03/01/1991 | WO1991000085A1 Sustained release pharmaceutical compositions |
03/01/1991 | CA2064189A1 Topical antiinflammatory compositions with minimal systemic absorption |
03/01/1991 | CA2024450A1 Gastric retention device |
03/01/1991 | CA2024171A1 Low-irritative nasal preparation |
03/01/1991 | CA2021408A1 Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein |
02/27/1991 | EP0414605A1 Pasty aqueous pharmaceutical compositions |
02/27/1991 | EP0414416A2 Aromatic polyanhydride compositions |
02/27/1991 | EP0414373A2 Stable solution of hyaluronate in a balanced salt medium |
02/27/1991 | EP0414263A2 Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids. |
02/27/1991 | EP0414233A2 Medical electrical lead with polymeric monolithic controlled realease device |
02/27/1991 | EP0414115A1 Granulates of riboflavine without excipients |
02/27/1991 | EP0413865A1 Process to prepare coated particles |
02/27/1991 | EP0413828A1 Solid preparation of active vitamin d3 having improved stability |
02/27/1991 | CN1049517A Prepn. of bee venom spirit |
02/27/1991 | CN1049455A Pharmaceutical dosage form improving bioavailability |
02/27/1991 | CN1049451A Antibiotic composition |
02/27/1991 | CN1049450A Method and device for administering dexmedetomidine transdermally |
02/27/1991 | CN1049442A Encapsulated flavor delivery system and method of preparation |
02/26/1991 | US4996222 Pharmaceutical formulations |
02/26/1991 | US4996197 Pharmaceutical and/or cosmetic composition for local use containing Rhamsan gum |
02/26/1991 | US4996196 Dehydrated product containing crystalline b-maltose hydrate |
02/26/1991 | US4996193 Combined topical and systemic method of administration of cyclosporine |
02/26/1991 | US4996074 Tailored beta-prime stable triglyceride hardstock |
02/26/1991 | US4996067 Feed additive for ruminants |
02/26/1991 | US4996061 Sustained release |
02/26/1991 | US4996060 Device comprising liner for protecting fluid sensitive medicament |
02/26/1991 | US4996058 Covered retard forms |
02/26/1991 | US4996047 Sustained release drug-resin complexes |
02/26/1991 | US4996004 Preparation of pharmaceutical or cosmetic dispersions |
02/26/1991 | US4995407 Tobacco-free, artificial flavoring material resembling both appearance and tactile sensation to cigaratte |
02/24/1991 | WO1991002517A1 Process for preparation of an oil in water emulsion of a drug |
02/23/1991 | WO1991002811A1 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
02/21/1991 | WO1991002033A1 Stable, fluid, aqueous pigment dispersions |
02/21/1991 | WO1991001803A1 Multilayer granules containing coated active substances, production method, device for implementing such method and utilization of the granules obtained |
02/21/1991 | WO1991001801A1 Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto |
02/21/1991 | WO1991001765A1 A phospholipid delivery system |
02/21/1991 | WO1991001734A1 Prednisone microencapsulated granules |
02/21/1991 | WO1991001723A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
02/21/1991 | WO1991001722A1 Diltiazem containing pharmaceutical compositions |
02/21/1991 | WO1991001720A1 Composition and method of promoting hard tissue healing |
02/21/1991 | WO1991001715A1 Ophthalmic compositions |
02/21/1991 | WO1991001714A1 Ophthalmic composition |
02/21/1991 | WO1990011782A3 Immunoconjugates and prodrugs and their use in association for drug delivery |
02/20/1991 | EP0413583A2 Clear, stable cromolyn formulation |
02/20/1991 | EP0413553A1 Biphasic transdermal drug delivery device |
02/20/1991 | EP0413539A2 Flavour delivery system and its preparation |
02/20/1991 | EP0413538A1 Long active injectable formulations containing triacetin |
02/20/1991 | EP0413533A1 Microencapsulated taste-masked water-insoluble NSAID drug materials |
02/20/1991 | EP0413528A1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
02/20/1991 | EP0413487A1 Method and device for administering dexmedetomidine transdermally |
02/20/1991 | EP0413427A2 Method for increasing salivation for xerostomia patients |
02/20/1991 | EP0413418A2 Aqueous dispersions of polymers cross-linked with metallic ions |
02/20/1991 | EP0413299A1 Antibiotic composition |
02/20/1991 | EP0413281A2 Drug carrier |
02/20/1991 | EP0413246A2 Reparation of parenteral forms, their application in a kit and 5-Fluorcytosin-Monochlorhydrate |
02/20/1991 | EP0413171A1 Strong analgesic composition and process for its preparation |
02/20/1991 | EP0413120A2 Aspirin granules with gastroprotectant coating |
02/20/1991 | EP0413061A1 Controlled-release oral dosage forms comprising different cellulose ethers |
02/20/1991 | EP0413034A1 Poultice and preparation thereof |
02/20/1991 | CN1049279A Low friction film dressing |
02/20/1991 | CN1011659B Preparation of a composition based on a finely divided active principle of low water solubility |
02/19/1991 | WO1991002704A1 Ferritin analogs |
02/19/1991 | WO1991002545A1 Pharmaceutical compositions |
02/19/1991 | WO1991002528A1 Ketotifen preparation for external use |
02/19/1991 | WO1991002505A1 Method and device for administering dexmedetomidine transdermally |
02/19/1991 | US4994496 Loading therapeutic agent into globule by incubation; topical, mouth or injection |
02/19/1991 | US4994458 Spraying a binder solution into fluidized cloud of riboflavin; batch process; free-flowing |
02/19/1991 | US4994441 Kappa-caseino-glycopeptides or desialylated derivatives |
02/19/1991 | US4994440 Administering phospholipidyl tripeptides |
02/19/1991 | US4994439 Transmembrane formulations for drug administration |
02/19/1991 | US4994281 Polylactic acid microspheres and process for producing the same |
02/19/1991 | US4994279 Multi-layer granule |
02/19/1991 | US4994278 Breathable backing |
02/19/1991 | US4994276 Directly compressible sustained release excipient |
02/19/1991 | US4994275 Trilaminate sheet containing medication rolled into tube closed by plugs and retained by film which disintegrates in rumen |
02/19/1991 | US4994273 Solubility modulated drug delivery device |
02/19/1991 | US4994267 Transdermal acrylic multipolymer drug delivery system |
02/19/1991 | US4994262 Oral compositions |
02/19/1991 | US4994260 Pharmaceutical mixture |
02/19/1991 | US4994227 Method for the preparation of sustained released bolus formulation |
02/19/1991 | US4994213 Dissolving in solvent; reverse osmosis |
02/19/1991 | US4994049 Application of transdermally active oil; absorptive carrier on laminate support |
02/19/1991 | US4994023 Electrochemical drug release and article |
02/19/1991 | US4993137 Gelatinizing cellulose ether solution adhered to pins by contacting with controlled high temperature water; uniformity, wrinkle resistance |
02/19/1991 | CA2064588A1 Ketotifen preparation for external use |
02/19/1991 | CA2064069A1 Ferritin analogs |
02/19/1991 | CA2021441A1 Process for the manufacture of parenteral application formulations |
02/19/1991 | CA1280367C Pharmaceutical composition of the type which undergoes liquid-gel phase transition |
02/19/1991 | CA1280279C Apparatus for continuous pan coating |
02/18/1991 | WO1991002553A2 Transdermal nitroglycerin patch with penetration enhancers |
02/18/1991 | WO1991002525A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
02/18/1991 | WO1991002520A1 Pharmaceutical formulations |
02/18/1991 | CA2064845A1 Transdermal nitroglycerin patch with penetration enhancers |
02/18/1991 | CA2062745A1 Composition based on hydrated lipidic lamellar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical composition, particularly dermatological composition containing it |